US2022314016A1PendingUtilityA1

Cancer treatment apparatus

Assignee: PUBLIC UNIV CORP YOKOHAMA CITY UNIVPriority: Nov 24, 2016Filed: Jun 9, 2022Published: Oct 6, 2022
Est. expiryNov 24, 2036(~10.3 yrs left)· nominal 20-yr term from priority
A61N 2/02
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A cancer treatment apparatus including a magnetic field generator that generates a magnetic field of 100 kHz to 300 kHz to be applied to affected tissues.

Claims

exact text as granted — not AI-modified
1 . A cancer treatment apparatus for treating a cancer comprising:
 a magnetic field generator that generates a magnetic field of which a frequency is ranged from 100 kHz to 300 kHz to be applied to affected tissues;   a power source that generates an alternating current to be supplied to the magnetic field generator, and   a control module that controls the alternating current supplied from the power source to the magnetic field generator, wherein   the control module controls the alternating current such that a magnetic flux density of the magnetic field, which is generated by the magnetic field generator, is a predetermined value,   a frequency and size of the alternating current supplied to the magnetic field generator varies in correspondence with output from the control module,   
     
     
         2 . The cancer treatment apparatus according to  claim 1 , wherein
 the control module controls the power source to maintain a temperature of the affected tissues lower than a cancer cell killing temperature.   
     
     
         3 . The cancer treatment apparatus according to  claim 1 , wherein
 the affected tissues are human affected tissues.   
     
     
         4 . The cancer treatment apparatus according to  claim 1 , wherein
 the predetermined value of the magnetic flux density is at least 18 mT or larger.   
     
     
         5 - 10 . (canceled) 
     
     
         11 . A treatment method for treating a cancer comprising:
 applying an alternating magnetic field to affected tissues.   
     
     
         12 . The treatment method for treating the cancer according to  claim 11 , wherein
 a frequency of the magnetic field is ranged from 100 kHz to 300 kHz.   
     
     
         13 . The treatment method for treating the cancer according to  claim 11 , wherein
 a frequency and size of the magnetic field is varied.   
     
     
         14 . The treatment method for treating the cancer according to  claim 11 , further comprising
 without using any heat generation medium; and   not using heat-generating effect of the affected tissues due to the irradiation of the magnetic field for treatment.   
     
     
         15 . The treatment method for treating the cancer according to  claim 11 , wherein
 a magnetic flux density of the magnetic field is a predetermined.   
     
     
         16 . The treatment method for treating the cancer according to  claim 11 , wherein
 the predetermined value of the magnetic flux density is at least 18 mT or larger.   
     
     
         17 . The treatment method for treating the cancer according to  claim 11 , further comprising
 controlling a power source to generate an alternating current to be supplied to a magnetic field generator such that the magnetic field is generated using the alternating current.   
     
     
         18 . The treatment method for treating the cancer according to  claim 11 , further comprising:
 inputting a cancer type of the affected tissues wherein the cancer type, which is input, is defined as an input cancer type,   determining the frequency of the magnetic field in correspondence with the input cancer type.   
     
     
         19 . The treatment method for treating the cancer according to  claim 11 , wherein
 type of the cancer is a glioblastoma, a malignant melanoma, a tongue cancer, a breast cancer, a malignant mesothelioma, a pancreatic cancer, or a human alveolar basal epithelial adenocarcinoma.

Join the waitlist — get patent alerts

Track US2022314016A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.